← Back to Search

Subjects requiring a Heart Transplant for Heart Failure

N/A
Recruiting
Research Sponsored by XVIVO Perfusion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 365.
Awards & highlights

Summary

The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.

Eligible Conditions
  • Heart Transplant
  • Heart Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 365.
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative day 365. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The percentage of patient survival
The percentage of patient treatment success rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Subjects requiring a Heart TransplantExperimental Treatment1 Intervention
Device: Preservation of hearts for transplant.

Find a Location

Who is running the clinical trial?

XVIVO PerfusionLead Sponsor
9 Previous Clinical Trials
1,004 Total Patients Enrolled
1 Trials studying Heart Failure
20 Patients Enrolled for Heart Failure
Jaya TiwariStudy DirectorXVIVO Perfusion
~86 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top